Eruptions in Patients with chronic hepatitis C receiving combination therapy with Telaprevir, Peginterferon and Ribavirin

被引：0
|
作者：
Eleftheriadis, V [1 ]
Stadler, R. [1 ]
机构：
[1] Johannes Wesling Klinikum Minden, Hautklin, Minden, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2012年 / 10卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
  • [31] Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
    Maekawa, Shinya
    Enomoto, Nobuyuki
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (10) : 1009 - 1015
  • [32] Therapy Induced Anemia in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon Alpha and Ribavirin
    Mehdi, Syed Ghazanfar
    Faizi, Karim Shah
    Khan, Rao Saad Ali
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (01): : 204 - 206
  • [33] The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
    Huang, Jee-Fu
    Yu, Ming-Lung
    Huang, Chung-Feng
    Juo, Suh-Hang Hank
    Dai, Chia-Yen
    Hsieh, Ming-Yen
    Hou, Nei-Jen
    Yeh, Ming-Lun
    Hsieh, Meng-Hsuan
    Yang, Jeng-Fu
    Lin, Zu-Yau
    Chen, Shinn-Chern
    Shin, Shyi-Jang
    Chuang, Wan-Long
    LIVER INTERNATIONAL, 2012, 32 (06) : 962 - 969
  • [34] Neurocognitive Changes in Chronic Hepatitis C Patients Receiving Combination Therapy of Interferon and Ribavirin: A Systematic Review
    Wani, Momin Altaf
    Agarwal, Nidhi B.
    Yasmeen
    Khan, Mohd Ashif
    CURRENT DRUG THERAPY, 2022, 17 (05) : 349 - 358
  • [35] Coffee Consumption Is Associated With Response to Peginterferon and Ribavirin Therapy in Patients With Chronic Hepatitis C
    Freedman, Neal D.
    Curto, Teresa M.
    Lindsay, Karen L.
    Wright, Elizabeth C.
    Sinha, Rashmi
    Everhart, James E.
    GASTROENTEROLOGY, 2011, 140 (07) : 1961 - 1969
  • [36] COST-UTILITY ANALYSIS OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALPHA AND RIBAVIRIN IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS IN A ROMANIAN SETTING
    Paveliu, M. S.
    Comsa, R.
    Mircea, R.
    VALUE IN HEALTH, 2013, 16 (07) : A499 - A499
  • [37] HIGHLY EFFECTIVE PEGINTERFERON ALPHA-2A PLUS RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C IN PATIENTS WITH HEMOPHILIA
    Lee, Hyun Woong
    Kim, Hyung J.
    Lee, Youn-Jae
    Park, Sung Jae
    Baek, Eun Kyung
    Kim, Ki-Seong
    Cha, Bong Ki
    Lee, Seung-Yong
    Oh, Hyoung-Chul
    Choi, Chang Hwan
    Kim, Jung Uk
    Do, Jae Hyuk
    Kim, Jae G.
    Chang, Sae Kyung
    HEPATOLOGY, 2009, 50 (04) : 1020A - 1020A
  • [38] Pretreatment insulin sensitivity contributes to the treatment response to peginterferon plus ribavirin combination therapy for patients with chronic hepatitis C
    Huang, Jee-Fu
    Yu, Ming-Lung
    Dai, Chia-Yen
    Hsieh, Ming-Yen
    Lee, Li-Po
    Lin, Zu-Yau
    Chen, Shinn-Chern
    Chang, Wen-Yu
    Chuang, Wan-Long
    HEPATOLOGY, 2007, 46 (04) : 349A - 349A
  • [39] Toward individualized therapy with peginterferon alpha/ribavirin for chronic hepatitis C
    Dai, Chia-Yen
    ADVANCES IN DIGESTIVE MEDICINE, 2015, 2 (01) : 3 - 5
  • [40] Retreatment with peginterferon and ribavirin in chronic hepatitis C
    Yong Min Jo
    Sung Wook Lee
    Sang Young Han
    Yang Hyun Baek
    Soo Young Kim
    Woo Jae Kim
    Ji Hye Ahn
    Ji Young Lee
    World Journal of Gastroenterology, 2015, (06) : 1994 - 1999
12345